| Case | Antimicrobial sensitivities | Antibiotics utilized | Antibiotic duration | Outcomes |
| Bacterial peritonitis secondary to peritoneal dialysis |
| 1 [8] | S: ampicillin, carbenicillin, colistin, smz/tmp | Carbenicillin IV | NR | Cure | R: AG, tetracycline | I: cephalothin |
| 2 [5] | S: colistin, moxalactam, cefamandole | Moxalactam ∗ | Likely 15 days | Deceased | R: piperacillin, azlocillin, ceftazidime, cefoperazone, novobiocin, minocycline | Noxytiolin IP | I: rifampin, rosoxacin |
| 3 [53] | S: smz/tmp, AG, carbenicillin | Tobramycin IP | 3 days | Relapse | Cephalothin IP | R: ampicillin, cefamandole, cefoxitin, cephalothin, tetracycline, chloramphenicol | smz/tmp IP | 10 days | Cure |
| 4 [54, 55] | R: AG | Vancomycin IP | 1 dose | Deterioration | Gentamicin IP | Complete sensitivity profile was not available. Initial response to gentamicin was documented by El-Shahawy, et al. [46]. | Gentamicin IP | NR | Deterioration | Ciprofloxacin PO | Piperacillin IV | 7 days | Cure |
| 5 [55] | S: ofloxacin | Vancomycin IP | 3 days | Cure | Ceftazidime IV | R: AG, aztreonam, cefazolin, cefotaxime, cefoxitin, ceftriaxone, ceftazidime, cefuroxime, ciprofloxacin, imipenem, piperacillin, smz/tmp | Ceftazidime IV | 14 days | Ofloxacin PO |
| 7 [56] | S: P/T | Cefazolin IP | 3 days | Cure | Tobramycin IP | R: ampicillin, cephalothin, ceftriaxone, AG, ciprofloxacin, smz/tmp | Amikacin IP | 3 days | Ceftazidime IP | P/T IV | 21 days |
| 8 [56] | S: piperacillin, ticarcillin, ceftriaxone, ceftazidime, smz/tmp | Cefazolin IP | 3 days | Cure | Tobramycin IP | R: AG | Amikacin IP | 5 days | Ceftazidime IP | P/T IV | 21 days |
| 10 [49] | S: ciprofloxacin, imipenem | Vancomycin IP | NR | Cure | Ceftazidime IP | Ciprofloxacin PO | R: ceftazidime, smz/tmp | Ceftazidime IP | Amikacin IP | smz/tmp PO | Imipenem IP | Ciprofloxacin PO |
| 11 [57] | S: imipenem, P/T | Ceftazidime IP | 1 dose | Cure | Cefazolin IP | R: cefotaxime, AG | Ciprofloxacin PO | NR | Imipenem IV | 3 doses | I: ciprofloxacin | Imipenem IP | 30 days | Ciprofloxacin PO | 10 days |
| 12 [58] | Complete sensitivity profile was not reported but ampicillin/sulbactam, ciprofloxacin and cefepime were definitive therapies | Ceftazidime IV | NR | Cure | Cefazolin IV | amp/sulb IV | 7 days | Ciprofloxacin∗ | 2 days | Cefepime∗ | 7 days |
| 13 [59] | S: ceftazidime, imipenem, meropenem, levofloxacin, piperacillin | Vancomycin IP | 7 days | Deterioration | Amikacin IP | R: NR | Imipenem/cil IP | 7 days | P/T IP | Ceftazidime | NR | Deceased | Cefazolin | Imipenem/cil | Vancomycin | Imipenem/cil IP | NR | Vancomycin IP | Imipenem/cil IV | 29 days | Vancomycin IV |
| 14 [60] | S: ceftazidime, cefepime, sulfonamide, quinolones, carbapenem, P/T | Ciprofloxacin PO | 14 days | Cure | R: NR |
| 15 [50] | Unable to obtain due to lack of article access | Cefazolin IP | 3 days | Cure | Ceftazidime IP | Ceftazidime IP | 4 days |
| 16 [43] | S: ciprofloxacin, others NR | Ciprofloxacin∗ | NR | Cure | R: NR |
| 17 [14] | S: amp/sulb, smz/tmp, carbapenem, cephoperazone/sulbactam, ceftazidime, P/T, tigecycline | Cephalosporin PO | 14 days | Relapse | R: 1st generation cephalosporin, ciprofloxacin | Cefazolin IP | 7 days | Cure | Ceftazidime IP | amp/sulb PO | 14 days |
| 18 [52] | S: P/T, ceftazidime, imipenem | Ceftazidime IP | NR | Replase | Cefazolin IP | R: ciprofloxacin, cefepime | Imipenem/cil∗ | 14 days | Imipenem IV | 14 days | Replase | Ceftazidime IV | Imipenem IV | 14 days | Cure | Ceftazidime IV |
| Sponteneous bacterial peritonitis |
| 6 [12] | S: amox/clav, ceftazidime, P/T, imipenem, meropenem, cotrimoxazole | Ceftriaxone IV | 10 days | Cure | I: cefotaxime, ceftriaxone, ofloxacin, ciprofloxacin | R: AG, aztreonam, cefazolin, cefuroxime | 9 [13] | S: NR | P/T IV | Few hours | Deceased (few hours later) | R: cefotaxime, aztreonam, AG, ciprofloxacin |
| Percutaneous endoscopic gastrostomy tube-associated peritonitis |
| 19 | S: P/T (≤2/4), smz/tmp (≤0.5/9.5), meropenem (0.25) | P/T IV | 4 days | Deterioration | R: aztreonam (16), cefepime (16), gentamicin (8) | Levofloxacin IV | 2 days | Deterioration | Metronidazole IV | I: amikacin (32), levofloxacin (4), tobramycin (8) | Linezolid IV | 7 days | Deterioration | Doxycycline IV | Meropenem IV | 4 days | Adverse reaction | Linezolid IV | Meropenem IV | 2 days | Transferred to UK | P/T IV | 2 days | Adverse reaction | Vancomycin IV | Cefepime IV | 4 days | Deterioration | Vancomycin IV | Metronidazole IV | P/T IV | 5 days | Deterioration | Meropenem IV | 4 days | Deceased | Vancomycin IV |
|
|
In case 2, the duration of treatment was not clearly reported but was likely 15 days; route of moxalactam was unreported. Case 12 did not report route of ciprofloxacin and cefepime; total of 20 days of antibiotics were administered as patient had presented with 5th episode of peritonitis; subsequently, hemodialysis was initiated. Case 13 reported total of 48 days of antimicrobial treatment. Case 16 did not report full culture and sensitivities, route of ciprofloxacin and total duration of the treatment. Case 18 does not report route of imipenem/cilastatin. Abbreviations: S = Sensitive, R = resistant, I = intermediate, smz/tmp = sulfamethoxazole/ trimethoprim, P/T = piperacillin/tazobactam, amp/sulb = ampicillin/sulbactam, amox/clav = amoxicillin/clavulanate, cil = cilastatin, AG = aminoglycosides, IV = intravenous, IP = intraperitoneal, PO = oral, NR = not reported.
|